Genetics of sarcoidosis, cardiac sarcoidosis and other inflammatory myocardial diseases

Description of the granted funding

Sarcoidosis is an inflammatory disease characterised by non-necrotising granulomas in multiple organs. The exact cause of sarcoidosis is unkown but the hypothesis is that environmental antigen in a genetically predisposed individual triggers dysregulated T-cell driven immunologic response. The incidence of sarcoidosis is highest in North Europe. Even half of patients may heal spontaneously but the prognosis varies depending on the disease severity and organs affected. Autopsy reports and imaging studies show cardiac involvement in 25-30% of patients. In Finland, cardiac sarcoidosis affects predominantly young and middle-aged adults, of whom >70% are women. Due to bottle-neck population, genes predisposing to sarcoidosis may be enriched in Finland. Using the FinnGen data of >500.000 genotyped individuals and the longitudinal Finnish health registers, we aim to identify genetic associations modifying the risk of sarcoidosis, severity of the disease, cardiac involvement and prognosis.
Show more

Starting year

2025

End year

2029

Granted funding

Pauli Pöyhönen Orcid -palvelun logo
234 935 €

Funder

Research Council of Finland

Funding instrument

Clinical researcher

Decision maker

Scientific Council for Biosciences, Health and the Environment
16.06.2025

Other information

Funding decision number

371279

Fields of science

Genetics, developmental biology, physiology

Research fields

Perinnöllisyystiede

Identified topics

cardiovascular diseases